Obesity Drug Pipeline 2026: The New Era of Metabolic Innovation
The obesity drug pipeline 2026 represents a monumental shift from simple appetite suppression to comprehensive metabolic restoration. As of March 2026, the landscape is no longer defined solely by injectable…